CJC-1295 Peptide Research Guide
מה זה פפטיד CJC-1295
Educational guide to CJC-1295 peptide including GHRH signaling pathways, research applications, and laboratory handling protocols
What is CJC-1295?
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that has been modified to increase its half-life and stability. Originally developed for research into growth hormone signaling pathways, CJC-1295 is supplied exclusively for laboratory research purposes.
The peptide consists of 30 amino acids and includes a Drug Affinity Complex (DAC) modification that allows it to bind to albumin in the bloodstream, significantly extending its biological half-life compared to natural GHRH. This makes CJC-1295 peptide a valuable tool for studying sustained growth hormone release patterns in research models.
At Peptides Israel, we provide comprehensive information about CJC-1295 research applications and proper laboratory handling protocols for scientific investigation.
Mechanism of Action
GHRH Receptor Binding
CJC-1295 binds to growth hormone-releasing hormone receptors on pituitary somatotroph cells, mimicking the action of endogenous GHRH to stimulate growth hormone secretion.
Extended Half-Life
The DAC modification allows CJC-1295 to bind to serum albumin, protecting it from degradation and extending its half-life to approximately 6-8 days in research models.
Sustained GH Release
Unlike pulsatile GHRP peptides, CJC-1295 provides sustained elevation of growth hormone levels, making it useful for studying chronic GH signaling effects in laboratory settings.
CJC-1295 with DAC vs Without DAC
| Property | CJC-1295 with DAC | CJC-1295 without DAC |
|---|---|---|
| Half-Life | 6-8 days | ~30 minutes |
| GH Release Pattern | Sustained elevation | Pulsatile release |
| Dosing Frequency | 1-2x per week | 2-3x per day |
| Also Known As | CJC-1295 DAC | Modified GRF 1-29 |
Research Areas Studied
Growth Hormone Signaling
CJC-1295 peptide is extensively studied for its effects on growth hormone secretion patterns, IGF-1 production, and downstream signaling cascades in research models.
- Pituitary GH secretion mechanisms
- IGF-1 pathway activation
- Sustained vs pulsatile GH release
Metabolic Research
Research investigates how CJC-1295 research compounds affect metabolic processes including protein synthesis, lipolysis, and glucose metabolism in laboratory settings.
- Protein synthesis pathways
- Lipolytic signaling mechanisms
- Glucose homeostasis regulation
Body Composition Studies
Scientists study the effects of sustained GH elevation on lean mass, adipose tissue, and body composition changes in research models.
- Lean tissue development
- Adipose tissue metabolism
- Body composition alterations
Synergistic Research
CJC-1295 peptide is often studied in combination with GHRP peptides like Ipamorelin to investigate synergistic effects on GH release patterns.
- GHRH + GHRP synergy
- Amplified GH secretion
- Combined signaling pathways
Half-Life Information
Extended Biological Half-Life
CJC-1295 with DAC has a biological half-life of approximately 6-8 days in research models. This extended duration is achieved through the Drug Affinity Complex modification, which allows the peptide to bind to serum albumin and resist enzymatic degradation.
The long half-life means that CJC-1295 peptide maintains elevated growth hormone levels for extended periods, making it suitable for research protocols requiring sustained GH signaling rather than pulsatile patterns.
In contrast, CJC-1295 without DAC (Modified GRF 1-29) has a much shorter half-life of approximately 30 minutes, similar to natural GHRH, allowing for more physiological pulsatile GH release patterns in research applications.
Research Implications
- Less frequent dosing in research protocols
- Sustained GH elevation studies
- Chronic GH signaling investigation
Stability Considerations
- Albumin binding protects from degradation
- Resistant to enzymatic breakdown
- Prolonged bioavailability in research
Storage Guidelines
Lyophilized Storage
Store lyophilized CJC-1295 peptide at -20°C or below in sealed containers protected from light and moisture.
Stability: 12-24 months when properly stored
Reconstitution
Use sterile bacteriostatic water or appropriate buffer solutions. Follow manufacturer specifications for concentration.
Typical concentration: 2-5 mg/mL
Reconstituted Storage
Store reconstituted CJC-1295 research compound at 2-8°C and use within recommended timeframes.
Stability: 7-14 days refrigerated
Laboratory Handling
All CJC-1295 peptide handling should be performed in appropriate laboratory settings following proper sterile technique protocols. Avoid repeated freeze‑thaw cycles and protect from direct light exposure.
Related Research Peptides
Ipamorelin
GHRP peptide often studied in combination with CJC-1295 for synergistic growth hormone release research.
Learn MoreTesamorelin
Another GHRH analog studied for its effects on growth hormone secretion and metabolic processes.
Learn MoreMOTS-C
Mitochondrial-derived peptide studied for metabolic regulation and longevity research applications.
Learn MoreFrequently Asked Questions
What is CJC-1295 peptide?
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that has been modified to increase its half-life and stability. It is used exclusively for laboratory research purposes to study growth hormone signaling pathways.
How does CJC-1295 work?
CJC-1295 works by binding to GHRH receptors on pituitary cells, stimulating the release of growth hormone. The DAC modification extends its half-life to approximately 6-8 days, allowing for sustained signaling in research models.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC (Drug Affinity Complex) has an extended half-life of 6-8 days due to albumin binding, while CJC-1295 without DAC (also called Modified GRF 1-29) has a shorter half-life of approximately 30 minutes, allowing for more pulsatile growth hormone release patterns in research.
Can CJC-1295 be combined with other peptides?
In research settings, CJC-1295 peptide is often studied in combination with GHRP peptides like Ipamorelin to investigate synergistic effects on growth hormone release. The combination of GHRH and GHRP peptides can produce amplified GH secretion in research models.
How should CJC-1295 be stored?
Lyophilized CJC-1295 research compound should be stored at -20°C or below, protected from light and moisture. Once reconstituted, store at 2-8°C and use within 7-14 days. Always follow proper laboratory handling protocols.
Learn More About CJC-1295 Research
Contact Peptides Israel for comprehensive information about CJC-1295 peptide research applications and laboratory protocols.
All compounds are supplied strictly for laboratory research purposes only. Not intended for human consumption.